Cognito Therapeutics today announced new data from its OVERTURE feasibility trial evaluating its Spectris neuromodulation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback